Zdrowie i gospodarka · 21/02/2023

FDA Clears Path for Abbreviated Approval of Topiramate Sprinkle Capsules

The US Food and Drug Administration has determined that the 50mg version of Topamax sprinkle capsules was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential FDA approval of generic versions of the medication.